Here we show that Mst1, a proapoptotic kinase, impairs protein quality control mechanisms in the heart through inhibition of autophagy. Stress-induced activation of Mst1 in cardiomyocytes promoted accumulation of p62 and aggresome formation, accompanied by the disappearance of autophagosomes. Mst1 phosphorylated the Thr108 residue in the BH3 domain of Beclin1, which enhanced the interaction between Beclin1 and Bcl-2 and/or Bcl-xL, stabilized the Beclin1 homodimer, inhibited the phosphatidylinositide 3-kinase activity of the Atg14L-Beclin1-Vps34 complex and suppressed autophagy. Furthermore, Mst1induced sequestration of Bcl-2 and Bcl-xL by Beclin1 allows Bax to become active, thereby stimulating apoptosis. Mst1 promoted cardiac dysfunction in mice subjected to myocardial infarction by inhibiting autophagy, associated with increased levels of Thr108-phosphorylated Beclin1. Moreover, dilated cardiomyopathy in humans was associated with increased levels of Thr108phosphorylated Beclin1 and signs of autophagic suppression. These results suggest that Mst1 coordinately regulates autophagy and apoptosis by phosphorylating Beclin1 and consequently modulating a three-way interaction among Bcl-2 proteins, Beclin1 and Bax.
a r t i c l e s Autophagy is a bulk degradation mechanism in which cytosolic proteins and organelles are sequestered into autophagosomes and degraded by lysosomes 1 . The large capacity of autophagosomes allows autophagy to remove damaged organelles and protein aggregates and maintain organelle function and protein quality. Suppression of autophagy below physiological levels through deletion of the gene encoding Atg5 induces heart failure with enhanced protein aggregation, suggesting that autophagy is required to maintain baseline heart function 2 . Autophagy is upregulated in various pathological conditions, including myocardial ischemia, ischemia-reperfusion and pressure overload [3] [4] [5] . Upregulation of autophagy during myocardial stress is generally compensatory, alleviating energy loss and scavenging damaged mitochondria and protein aggregates 3, 6 . On the other hand, deregulated activation of autophagy can lead to excessive degradation of proteins and organelles and eventual cell death. Ischemia-reperfusion markedly upregulates Beclin1 and stimulates massive autophagy in the heart, and suppression of autophagy by downregulation of Beclin1 attenuates myocardial injury 4 . A possible explanation for the dichotomous function of autophagy in the heart is that autophagic activity either above or below the physiological range is detrimental 7, 8 . Currently, however, the signaling mechanisms responsible for maintaining autophagic activity within this range is poorly understood.
Beclin1, a Bcl-2 homology 3 (BH3) domain-only protein 9 , plays an important part in both autophagosome formation and autolysosome fusion. Beclin1 and the class III phosphatidylinositide 3-kinase (PI3K) Vps34 form two distinct complexes 10 . In complex I, which mediates autophagosome formation, Atg14L bridges Beclin1 and the Vps34-p150 complex, whereas in complex II, which regulates the vacuolar protein sorting pathway, UVRAG bridges Beclin1 and the Vps34-p150 complex 11 . The kinase activity of the Beclin1-Vps34 complex is negatively regulated by Bcl-2 family proteins 12 , which bind to Beclin1 and disrupt the interaction between Beclin1 and Vps34, leading to Beclin1 homodimer formation and inhibiting autophagosome formation 7 . However, it remains unclear how Beclin1 and Bcl-2 family proteins associate with one another and induce formation of the inactive Beclin1 homodimer under unstressed conditions. Mst1 (mammalian Ste20-like kinase 1) is a serine-threonine kinase and a component of the Hippo signaling pathway, which regulates apoptosis and organ size 13 . Mst1 is one of the protein kinases most strongly activated during cardiomyocyte apoptosis 14 through either a Rassf1A-dependent 15 or a caspase-dependent [14] [15] [16] mechanism. Persistent Mst1 activation in the heart induces dilated cardiomyopathy (DCM), whereas inhibition of endogenous Mst1 prevents apoptosis and cardiomyopathy in response to pathologically relevant stresses 14, 16 . Based on preliminary studies suggesting that Mst1 facilitates accumulation of protein aggresomes and p62 (also known as SQSTM1) in the heart in vivo, we tested the hypothesis that Mst1 Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2 activation in response to stress inhibits autophagy, detrimentally affecting cardiomyocytes and promoting heart failure.
RESULTS

Mst1 promotes cardiac dysfunction by inhibiting autophagy
We previously showed that endogenous Mst1 promotes left ventricular dysfunction after myocardial infarction 16 . Heart failure is often accompanied by an accumulation of damaged proteins and organelles in the form of aggresomes. Histological analyses of mouse hearts with chronic myocardial infarction showed that aggresomes accumulate in the perinucleus of border zone and remote-area cardiomyocytes (Fig. 1a) . The aggresomes colocalized with p62, a protein known to be degraded by autophagy, suggestive of insufficient clearance of aggresomes by autophagy (Fig. 1a) . The accumulation of aggresomes and p62 was markedly attenuated in transgenic mice with cardiacspecific overexpression of a dominant-negative version of Mst1 (Tg-DN-Mst1 mice) and in Mst1 −/− mice, suggesting that endogenous Mst1 negatively affects protein and organelle quality control in hearts after myocardial infarction ( Fig. 1a) . Autophagy was activated in the heart after myocardial infarction, as evidenced by accumulation of GFP-LC3 puncta in the border zone in transgenic mice harboring GFP-LC3 (Tg-GFP-LC3 mice) ( Fig. 1b) and an increase in LC3-II amounts (Fig. 1c) . Suppression of Mst1 enhanced expression of indicators of autophagy in the hearts after myocardial infarction (Fig. 1b,c) , suggesting that endogenous Mst1 negatively regulates autophagy. In order to elucidate the role of autophagy in mediating the protection against heart failure after myocardial infarction observed in Tg-DN-Mst1 mice 16 and Mst1 −/− mice (Supplementary Fig. 1b-d) , we crossed Tg-DN-Mst1 mice with Becn1 +/− mice (Becn1 encodes Beclin1). In Becn1 +/− Tg-DN-Mst1 hearts, the reduction in protein aggregation and in p62 accumulation observed in Tg-DN-Mst1 mice was reversed, and the increase in the number of GFP-LC3 puncta was attenuated ( Fig. 1a-c and Supplementary Fig. 1a) . These results confirm that the enhancement of autophagy observed in Tg-DN-Mst1 hearts was normalized in Becn1 +/− Tg-DN-Mst1 hearts. Furthermore, the suppression of left ventricular remodeling, the enhanced contraction of the scar, improved left ventricular function and increased survival rate observed in Tg-DN-Mst1 mice after myocardial infarction were all reversed in Becn1 +/− Tg-DN-Mst1 mice (Fig. 1d,e and Supplementary Fig. 1b-d) . These results suggest that autophagy has an important role in mediating the protective effects of Mst1 suppression in the heart after myocardial infarction.
Mst1 promotes protein aggregate accumulation in cardiomyocytes
We next examined whether Mst1 activation is sufficient to induce aggresome formation. Mice transgenically expressing Mst1 in cardiac tissue (Tg-Mst1 mice) exhibited more polyubiquitinated protein ( Fig. 2a and Supplementary Fig. 1e ) and stronger colocalization of vimentin and αB-crystallin in the perinucleus of cardiomyocytes than did nontransgenic (NTg) mice ( Supplementary Fig. 1f ). Colocalization of aggresomes and p62 was markedly greater in Tg-Mst1 than in NTg mice ( Fig. 2b) . We also observed increased colocalization of aggresomes and p62 in cultured neonatal rat cardiomyocytes 72 h after transduction with adenovirus harboring Mst1 (Ad-Mst1) compared to those with control adenovirus harboring LacZ (Ad-LacZ) ( Fig. 2c and Supplementary Fig. 1g ), indicating a cell-autonomous effect. Using transmission electron microscopy (TEM), we observed electron-dense amorphous structures that had the characteristics of aggresomes 17 in cardiomyocytes of Tg-Mst1 mice ( Fig. 2d and Supplementary Fig. 1h ). These results suggest that Mst1 activation is sufficient to stimulate protein aggregation. Mst1 overexpression in cardiomyocytes suppressed long-lived protein degradation ( Fig. 2e) . Conversely, transduction of neonatal rat cardiomyocytes with adenoviruses harboring DN-Mst1 (Ad-DN-Mst1) or an shRNA targeting Mst1 (Ad-sh-Mst1), which effectively regulated Mst1 in cardiomyocytes ( Supplementary Fig. 4e ), increased long-lived protein degradation under both nutrient-rich and starved conditions ( Fig. 2e) . We then investigated the effect of Mst1-induced aggresome accumulation on cardiomyocyte survival independent of the proapoptotic effect of Mst1. Although the increase in cell death induced by Mst1 overexpression was suppressed by zVAD-fmk, a pancaspase inhibitor, during the initial 48 h after Mst1 transduction, the inhibitor was unable to suppress Mst1-induced cell death at the 72 h time point after transduction, and aggresome formation was observed at this time point ( Supplementary Fig. 1i ). Thus, Mst1 erodes protein quality control, thereby promoting cell death in cardiomyocytes.
Mst1 directly inhibits autophagy in cardiomyocytes
As the enhancement of autophagy in Tg-DN-Mst1 and Mst1 −/− mice during chronic myocardial infarction might be due to an indirect effect of improved cardiac function, we next tested if Mst1 has a direct effect on autophagy. There were significantly fewer autophagosomes (as assessed by TEM) and GFP-LC3 puncta in Tg-Mst1 mice than in NTg mice at baseline, and this difference persisted after starvation of the mice, a well-established procedure for inducing autophagy ( Fig. 2f and Supplementary Fig. 2a,b) . Conversely, there were significantly more autophagosomes in Tg-DN-Mst1 and Mst1 −/− mice than in NTg mice both at baseline and after starvation ( Fig. 2f and Supplementary  Fig. 2a,b) . Moreover, there was significantly (P < 0.05, Supplementary  Fig. 2c ) less LC3-II and significantly more p62 in Tg-Mst1 than in NTg hearts, as well as significantly more LC3-II and significantly less p62 in Tg-DN-Mst1 and Mst1 −/− than in NTg hearts ( Fig. 2g and Supplementary Fig. 2c ). These results suggest that Mst1 inhibits autophagy in a cell-autonomous manner. Overexpression of Mst1 in Tg-Mst1 mice significantly (P < 0.01) inhibited accumulation of GFP-LC3 puncta in the presence of chloroquine (10 mg per kg body weight, intraperitoneal injection), an inhibitor of autophagosome-lysosome fusion 18 (Supplementary Fig. 2d ).
In cells expressing mRFP-GFP-LC3, LC3 associated with autophagosomes can be visualized as puncta that are both red and green (appearing yellow in the merged image), whereas autolysosomes are visualized as puncta that are red only. In cardiomyocytes transduced with Ad-mRFP-GFP-LC3 (ref. 19 ), Mst1 overexpression significantly decreased the number of both green and red puncta as compared to control cardiomyocytes transduced with LacZ ( Supplementary Fig. 2e ). In response to glucose deprivation (GD), a well-established procedure to induce autophagy in cardiomyocytes, Mst1 overexpression led to a significantly smaller increase in the number of red puncta, corresponding to autolysosomes, than yellow puncta, corresponding to autophagosomes ( Fig. 2h) . Conversely, in response to GD, knockdown of Mst1 significantly increased the number of both green and red puncta, with a significantly greater increase in the number of red puncta than in the number of yellow puncta ( Fig. 2h and Supplementary Fig. 2e ). Mst1 overexpression in cardiomyocytes inhibited autophagic flux at baseline and after GD, as evidenced by a decrease in LC3-II and an increase in p62 amounts, as well as a decrease in the number of GFP-LC3 puncta in the presence of bafilomycin A1, a lysosomal inhibitor used to evaluate autophagic flux ( Supplementary Fig. 2f,g) . Conversely, inhibition of endogenous Mst1 stimulated autophagic flux, suggesting that Mst1 suppresses a r t i c l e s 1 4 8 0 VOLUME 19 | NUMBER 11 | NOVEMBER 2013 nature medicine
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Becn1 autophagic flux in a cell-autonomous manner ( Supplementary  Fig. 2f,g) . We next investigated whether autophagy is also suppressed by other components of the Hippo pathway, including WW45 and Lats2. WW45 downregulation moderately promoted autophagy, but increasing Lats2 expression did not modulate autophagy ( Supplementary Fig. 2h ), suggesting that components of the Hippo pathway upstream of Mst1 (e.g., WW45) negatively affect autophagy through Mst1, whereas those downstream of Mst1 (e.g., Lats2) may not. GD-induced autophagy was also enhanced in both Mst1 −/− and Mst1 −/− ; Stk3 −/− (here called Mst1 −/− ; Mst2 −/− ) mouse embryonic fibroblasts (MEFs) as compared to wild-type MEFs ( Supplementary  Fig. 2i,j) , suggesting that Mst1 suppression of autophagy also occurs in other cell types. Although Mst2 has overlapping functions with Mst1, suppression of Mst1 was sufficient to stimulate autophagy in MEFs.
Mst1 directly inhibits the Beclin1-Vps34 complex
In order to elucidate how Mst1 inhibits autophagy, we investigated whether Mst1 interacts with the autophagy-associated proteins - npg a r t i c l e s Ulk1, Atg4B, Atg5, Beclin1, Atg7 and LC3 in cardiomyocytes using immunoprecipitation assays. Endogenous Beclin1 strongly interacted with Mst1 both in vitro and in vivo, whereas Ulk1, a homolog of yeast Atg1, only weakly interacted with Mst1 in vitro ( Fig. 3a and Supplementary Fig. 3a,b) . None of the other autophagy-associated proteins tested interacted with Mst1. Mst1 overexpression significantly decreased Vps34 lipid kinase activity in cardiomyocytes (P < 0.05, Supplementary Fig. 3c ). The activity of Atg14L-associated Vps34, reflecting complex I activity 10, 11 , was also significantly suppressed in the presence of Mst1 (Fig. 3b) . The number of GFP-2×FYVE Figure 3 Mst1 physically interacts with Beclin1 and enhances its binding to Bcl-2 and Bcl-xL, thereby inhibiting the kinase activity of the Beclin1-Vps34 (class III PI3K) complex. (a) Immunoprecipitation assays testing physical interactions between Mst1 and proteins encoded by autophagy-related genes in cultured cardiomyocytes. Forty-eight hours after transduction with or without Ad-Mst1, lysates were extracted for immunoprecipitation with Mst1-specific antibody or control IgG, followed by probing with antibodies specific for Ulk1, Atg4B, Atg5, Beclin1, Atg7 or LC3. The blots shown are representative of three independent experiments. (b) Lipid kinase assay of Beclin1-Vps34 complex. Cardiomyocytes were transduced with Ad-Mst1 or Ad-LacZ. Left, endogenous Vps34 complex was immunoprecipitated using Atg14L-specific antibody for the in vitro kinase assay, and the resulting radioactive phosphatidylinositol 3-phosphate (PtdIns(3,4,5)P 3 ), a reaction product, was separated by thin-layer chromatography (TLC). Right, radioactive PtdIns(3,4,5)P 3 was excised from thin layer plates and the radioactivity was measured in a liquid scintillation β-counter (LSC) (four independent experiments per group). Data are expressed as mean ± s.e.m. In 5% input immunoblot images, 5% of the amount of the total lysates used in each immunoprecipitation experiment was loaded in each lane. (c) Membrane-associated PI3K assay in situ. Cardiomyocytes were transduced with Ad-Mst1, Ad-DN-Mst1, Ad-sh-Mst1 or Ad-LacZ 24 h after Ad-GFP-2×FYVE transduction and then treated with or without 3-methyladenine (MA) (5 mM) or glucose deprivation (starvation) for 2 h. Top, representative images of GFP-2×FYVE dots. Bottom, quantitative analysis of the number of GFP-2×FYVE dots (six independent experiments per group). Data are expressed as mean ± s.e.m. *P < 0.05 compared to Ad-LacZ without starvation. Scale bar, 30 µm. (d) Cardiomyocytes were transduced with Ad-Mst1 or Ad-LacZ. Forty-eight hours after transduction, lysates were subjected to immunoprecipitation with Atg14L-specific antibody, Vps34-specific antibody or control IgG, followed by immunoblotting with Beclin1-specific antibody. (e) Cardiomyocytes were transduced with or without Ad-Mst1. Forty-eight hours after transduction, lysates were extracted for immunoprecipitation with Beclin1-specific antibody or control IgG, followed by immunoblotting with antibodies specific to Bcl-2, Bcl-xL, Atg14, UVRAG or Rubicon. The data shown are representative of three independent experiments. (f) Heart homogenates obtained from NTg, Tg-Mst1, Tg-DN-Mst1 or Mst1 −/− mice were immunoprecipitated with Atg14L-specific antibody or control IgG, followed by immunoblotting with Beclin1-specific antibody. The blots shown are representative of three independent experiments from three mice per group. (i) To assess Beclin1 homodimerization, cardiomyocytes were transduced with Ad-3×Flag-Beclin1-WT and Ad-3×HA-Beclin1-WT with or without Ad-Mst1. Forty-eight hours after transduction, lysates were subjected to immunoprecipitation with HA-specific or Flag-specific antibody, followed by immunoblotting with Flag-specific or HA-specific antibody, respectively. The blots shown are representative of three independent experiments. Beclin1
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npg a r t i c l e s nature medicine VOLUME 19 | NUMBER 11 | NOVEMBER 2013 dots, which reflects binding of GFP-2×FYVE to PI3P produced by Vps34 on autophagosomes and thereby indicates in situ activity of the Beclin1-Vps34 complex 20 , was also significantly decreased by Mst1 overexpression but was increased by inhibition of endogenous Mst1 (Fig. 3c) . These results suggest Mst1 negatively regulates Beclin1-Vps34 complex activity. As expected, stimulation of autophagy by starvation increased the number of GFP-2×FYVE dots, whereas suppression of autophagy by 3-MA decreased this number; these treatments served as positive and negative controls, respectively. Mst1 considerably attenuated the interactions between Beclin1 and Vps34 and between Beclin1 and Atg14L ( Fig. 3d ), suggesting that Mst1 induces dissociation of complex I. Complex I activity is modulated by several Beclin1-interacting proteins. We evaluated whether Mst1 affects interactions between Beclin1 and Bcl-2, Bcl-xL, Rubicon, Atg14L or UVRAG using immunoprecipitation assays in rat cardiomyocytes. Mst1 considerably enhanced binding of both Bcl-2 and Bcl-xL to Beclin1 but attenuated Atg14L binding to Beclin1, both in vitro and in vivo (Fig. 3e,f) . Neither Rubicon nor UVRAG binding to Beclin1 was affected by Mst1. The binding of Beclin1 to Atg14L was markedly increased, and the binding of Bcl-2 and Bcl-xL to Beclin1 was significantly (P < 0.05) attenuated, in Tg-DN-Mst1 and Mst1 −/− mouse hearts compared to NTg hearts ( Fig. 3f and Supplementary Fig. 3d ), suggesting that Mst1 kinase activity mediates the interaction between Beclin1 and both Bcl-2 and Bcl-xL, which is known to disrupt the interaction between Beclin1 and Vps34. Mst1 suppression of autophagy was abolished when Bcl-2 and Bcl-xL were downregulated ( Fig. 3g and Supplementary Fig. 3e ). Mst1 inhibition of autophagy in cardiomyocytes was dose-dependently reversed by treatment with ABT-737 ( Fig. 3h and Supplementary Fig. 3f) , a BH3 mimetic 21 that significantly (P < 0.05, Supplementary Fig. 3f ) decreased the Mst1-induced increase in Bcl-2 binding to Beclin1 in cardiomyocytes (Supplementary Fig. 3g) . These results suggest that Mst1's inhibition of autophagy is mediated by the interaction between the BH3 domain of Beclin1 and Bcl-2 and/or Bcl-xL.
Beclin1 associates with Atg14L when autophagy is stimulated but homodimerizes when Beclin1 is inactive 22, 23 . Co-immunoprecipitation assays showed thatMst1 overexpression stimulated association between Flag-tagged Beclin1 and hemagglutinin (HA)-tagged Beclin1 (Fig. 3i ), suggesting that Mst1 inhibits the interaction between Beclin1 and complex I by promoting formation of the inactive Beclin1 homodimer [22] [23] [24] [25] .
Mst1 phosphorylates Beclin1 at Thr108 in the BH3 domain In vitro kinase assays showed that full-length Beclin1 tagged with GST (GST-Beclin1-WT) and a Beclin1 fragment containing amino acids 72-163 (Beclin1-N2), but not other fragments, can be phosphorylated by Mst1 (Fig. 4a,b and Supplementary Fig. 4a ). Mass spectrometry analysis showed that the Thr108 residue of Beclin1, located in the BH3 domain and highly conserved across species, was phosphorylated by Mst1 ( Fig. 4c and Supplementary Fig. 4b) . GST-Beclin1-T108A was not phosphorylated by Mst1 ( Supplementary  Fig. 4c ), suggesting that Thr108 is the major site of phosphorylation by Mst1. Immunoblot analyses with Thr108-phosphorylated Beclin1-specific antibody showed that Mst1 but not DN-Mst1 overexpression leads to increased phosphorylated Beclin1 levels in cardiomyocytes both in vivo and in vitro (Fig. 4d) . Thr108-phosphorylated Beclin1 accumulated to a markedly greater degree in the perinucleus of cardiomyocytes in Tg-Mst1 mice than in NTg mice (Fig. 4e) . Moreover, Thr108-phosphorylated Beclin1 localized to the perinucleus of unstimulated cardiomyocytes was reduced markedly by Mst1 downregulation (Supplementary Fig. 4d ). Thr108-phosphorylated Beclin1 colocalized with the KDEL (Lys-Asp-Glu-Leu) motif, a marker of the endoplasmic reticulum (ER), but not with TGN46, a marker of the Golgi apparatus, or with Mitotracker, a mitochondrial marker ( Fig. 4f and Supplementary Fig. 4e) . These results suggest that Mst1 phosphorylates ER-localized Beclin1.
Mst1-induced phosphorylation homodimerizes Beclin1
We next explored the functional significance of the phosphorylation of Beclin1 by Mst1. The interaction between GST-Beclin1-WT and Bcl-2 was enhanced when GST-Beclin1-WT was phosphorylated by Mst1 (Fig. 5a) . GST-Beclin1-T108D, a phosphomimetic mutant, interacted with both Bcl-2 and Bcl-xL to the same extent as GST-Beclin1-WT phosphorylated by Mst1, but GST-Beclin1-T108A was less able to interact with Bcl-2 and Bcl-xL than GST-Beclin1-WT, and treatment of GST-Beclin1-T108A with Mst1 had no effect on its ability to interact with Bcl-2 or Bcl-xL ( Fig. 5b) . Phosphorylation of GST-Beclin1-WT by death-associated protein kinase (DAPK) decreased the interaction between GST-Beclin1-WT and Bcl-2 ( Fig. 5a) , as shown previously 26 , confirming the specificity of our assay. These results suggest that Mst1 directly stimulates the interaction between Beclin1 and Bcl-2.
The crystal structure of the Beclin1-Bcl-xL complex 27 revealed that the Thr108 residue of Beclin1 is located in the N terminus of the BH3 domain and interacts with the α3 helix of Bcl-xL at the entrance of the hydrophobic groove ( Supplementary Fig. 5a,b) . As His113 of Bcl-xL is a basic amino acid residue with a positive electric charge, phosphorylation of Thr108, which confers a negative charge to Thr108, would be expected to enhance its interaction with His113. Consistent with this hypothesis, replacement of His117 of mouse Bcl-2, which corresponds to His113 of human Bcl-xL, to alanine dramatically decreased the interaction between GST-Beclin1-WT and Bcl-2, even in the presence of Mst1 (Fig. 5c) .
In vitro binding assays using recombinant proteins showed that Bcl-2 interacts not only with GST-Beclin1-N2, which contains the BH3 domain, but also with GST-Beclin1-MID (amino acids 150-284), which contains the coiled-coil domain (CCD). Treatment with Mst1 enhanced the interaction of Bcl-2 with GST-Beclin1-N2 but not with GST-Beclin1-MID (Fig. 5d) . This suggests that the Bcl-2 interaction with the Beclin1 CCD is independent of Mst1. GST-Beclin1-MID could not interact with truncated Bcl-2 missing its BH4 domain, suggesting that the Beclin1 CCD binds to Bcl-2 in its BH4 domain (Fig. 5e) . Beclin1 homodimerization increased dramatically when Beclin1-WT was incubated with Bcl-2-WT, which had been phosphorylated by Mst1, but this did not occur in the absence of either Mst1 treatment or Bcl-2 ( Fig. 5f and Supplementary Fig. 5c ). These results suggest that phosphorylation of Beclin1 by Mst1 promotes Beclin1 homodimerization by enhancing the interaction between Beclin1 and Bcl-2 (Supplementary Fig. 5d ).
Mst1-induced phosphorylation of Beclin1 inhibits autophagy
We next investigated how Thr108 phosphorylation of Beclin1 affects autophagy. Beclin1-T108D suppressed the Vps34 kinase activity of the Atg14L-Beclin1 complex and significantly decreased the number of GFP-2×FYVE dots, reflecting PI3P associated with autophagosomes, even in the absence of Mst1 overexpression (Fig. 5g,h) . Conversely, Mst1 overexpression failed to suppress Vps34 kinase activity or reduce the number of GFP-2×FYVE dots in the presence of Beclin1-T108A (Fig. 5g,h) . The number of GFP-LC3 puncta in cultured cardiomyocytes was increased in the presence of Beclin1-T108A compared to npg a r t i c l e s Beclin1-WT under baseline conditions (Fig. 6a) . Under starved conditions, Beclin1-T108A abolished the Mst1-induced decrease in the number of GFP-LC3 puncta. Conversely, Beclin1-T108D decreased the number of GFP-LC3 puncta in cardiomyocytes under starved conditions, even in the absence of Mst1 overexpression (Fig. 6a) . We obtained similar results with immunoblot analyses (Supplementary Fig. 6a) . These results suggest that phosphorylation of the Thr108 residue of Beclin1 by Mst1 in cardiomyocytes negatively affects autophagy.
As Bcl-2 and Bcl-xL also bind to other BH3 domain-containing proteins, including Bax, modulation of the interaction between Beclin1 and Bcl-2 and/or Bcl-xL may affect Bax function. Bax knockdown significantly suppressed Mst1-induced apoptosis (P < 0.05, Supplementary Fig. 6b ), suggesting that Mst1 stimulates cardiomyocyte apoptosis through Bax. We next tested whether Mst1, in addition to promoting the interaction between Beclin1 and Bcl-2, would also attenuate the interaction between Bcl-2 and Bax, allowing Bax to take an active conformation. Beclin1-T108D enhanced the interaction between Beclin1 and Bcl-2, decreased the interaction between Bax and Bcl-2 and increased the amount of active Bax, even in the absence of Mst1 overexpression (Fig. 6b) . In contrast, Beclin1-T108A neither increased the interaction between Beclin1 and Bcl-2 nor decreased the interaction between Bax and Bcl-2, such that Bax remained inactive, even with Mst1 overexpression (Fig. 6b) . Beclin1-108D significantly increased the number of TUNEL-positive cardiomyocytes and the amount of cleaved caspase-3, even in the absence of Mst1 overexpression, whereas Beclin1-T108A suppressed Mst1-induced increases in the number of TUNEL-positive cardiomyocytes and the amount of cleaved caspase-3 (Fig. 6c) . Thus, an Mst1-induced increase in the interaction of Beclin1 with Bcl-2 family proteins in cardiomyocytes not only inhibits autophagy but also enhances apoptosis through dissociation of Bcl-2 from Bax (Supplementary Fig. 6c ).
As Mst1 can induce apoptosis through Bax, whether or not the suppression of autophagy by Mst1 independently contributes to cell death remains to be elucidated. We tested whether the suppression of autophagy by Mst1 induces cell death independently of apoptosis using Bax −/− ; Bak1 −/− MEFs. Mst1 inhibited GD-induced autophagy and increased accumulation of aggresomes in Bax −/− ; Bak1 −/− and wild-type MEFs (Supplementary Fig. 6d-f (Supplementary Fig. 6g) . These results suggest that Mst1 promotes cell death independently of Bax-or Bak-mediated pathways by inhibiting autophagic activity and promoting protein aggregate accumulation. (Supplementary Fig. 6h,i) , suggesting that Atg7 downregulation and Mst1 impair protein quality control through a common mechanism. Overexpression of Mst1 in Atg7 −/− MEFs reduced survival after 48 and 72 h compared to LacZ transduction, suggesting that the proapoptotic effect of Mst1 can kill MEFs independently of autophagy suppression (Supplementary Fig. 6j ).
Mst1 phosphorylates Beclin1 in the failing heart
We next investigated whether the Thr108 residue of Beclin1 is phosphorylated in the heart after myocardial infarction. Six weeks after myocardial infarction surgery in mice, the amount of Thr108phosphorylated Beclin1 was substantially elevated in NTg hearts but not in Tg-DN-Mst1 or Mst1 −/− hearts, suggesting that endogenous Mst1 phosphorylates Beclin1 in cardiomyocytes after myocardial infarction (Fig. 6d,e) . Our data suggest that increased activation of Mst1 inhibits autophagy to below the physiological range by promoting the Beclin1-Bcl-2 interaction, thereby inducing chronic heart failure. On the other hand, we have previously shown that excessive activation of autophagy beyond the physiological range causes cell death, thereby impairing cardiac function 4 . Notably, the amount of Beclin1 protein is strongly upregulated by ischemia-reperfusion 4 , followed by a gradual decrease in the chronic phase of myocardial infarction ( Supplementary  Fig. 6k) . Although the activity of Mst1 is upregulated during stress conditions ( Supplementary Fig. 6k and ref. 14) , the amount of endogenous Mst1 molecules is limited, such that strong upregulation of Beclin1 should result in an increase in the amount of unphosphorylated Beclin1 and subsequent activation of the Vps34 complex. Accordingly, we found increased amounts of unphosphorylated Beclin1 after myocardial ischemia-reperfusion ( Supplementary  Fig. 6l) . Moreover, Beclin1 overexpression in cardiomyocytes alleviated Mst1-induced suppression of autophagy ( Supplementary  Fig. 6m ). Thus, we propose that the extent of autophagy in the heart may be modulated by the balance between Mst1 activation and Beclin1 expression.
Finally, we investigated whether the Mst1-Beclin1 interaction might have detrimental effects in human failing hearts. Mst1 activity and the amount of Thr108-phosphorylated Beclin1 were substantially higher in failing hearts from individuals with end-stage DCM who had received heart transplants than in hearts from donors with normal cardiac function ( Fig. 6f and Supplementary Table 1) . Moreover, the amount of p62 was higher, and the LC3-II amount was lower, in failing compared to control hearts (Fig. 6f) , suggesting that autophagy is suppressed in human failing hearts. Staining of myocardial sections showed more prominent colocalization of aggresomes with p62 in the perinucleus of cardiomyocytes in failing compared to control hearts (Fig. 6g) .
DISCUSSION
A variety of disorders, collectively termed proteinopathies, are characterized by intracellular deposition of aggresomes, including neurodegenerative disorders, liver insufficiencies and heart failure caused by volume and pressure overload 28, 29 . Abnormalities in protein degradation mechanisms, namely the ubiquitin proteasome system and autophagy, can cause proteinopathies, but how these mechanisms are regulated by stress-signaling pathways is poorly understood. We demonstrate here that Mst1, a proapoptotic kinase, facilitates proteinopathy in a chronic myocardial infarction model by directly inhibiting autophagy through phosphorylation of Beclin1, a key regulator of autophagosome formation. Mst1-induced phosphorylation of Beclin1 induces interdependent modulation of Beclin1, Bcl-2 and Bcl-xL and/ or Bax, thereby regulating autophagy and apoptosis simultaneously. Furthermore, hearts of humans with end-stage DCM show enhanced Mst1 activation, Beclin1 phosphorylation, attenuation of autophagy and protein aggregate accumulation.
The Hippo pathway has recently emerged as a tumor suppressor signaling pathway 30 . The ability of Mst1 to regulate both autophagy and apoptosis may contribute to its tumor suppressor suppression by eliminating an adaptive mechanism for cancer cell survival in a hypoxic environment and promoting cell death.
The interactions of Beclin1 with Bcl-2 family proteins can be modulated by phosphorylation, including phosphorylation of Beclin1 in its BH3 domain by DAPK and Bcl-2 in its nonstructural loop by Jnk1, thereby promoting dissociation of Beclin1 from Bcl-2, which, in turn, induces autophagy 26, 31, 32 . Basal interaction between Beclin1 and Bcl-2 and/or Bcl-xL is a prerequisite for these mechanisms to be able to activate autophagy. However, the binding affinities of Bcl-2 and Bcl-xL to Beclin1 are low, except in the case of Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus 11, 23, 24 , raising the question of how a basal interaction between Beclin1 and Bcl-2 and/or Bcl-xL can take place. Our results show that Mst1-induced phosphorylation of Beclin1 at the Thr108 residue in its BH3 domain promotes the binding of Beclin1 with Bcl-2 and/or Bcl-xL. As the interaction between Beclin1 and Bcl-2 and/or Bcl-xL is markedly reduced when Mst1 activity is inhibited, the kinase activity of Mst1 likely regulates the basal interaction between Beclin1 and Bcl-2 and/or Bcl-xL.
The Beclin1 CCD acts as a central interaction platform for either homodimerization and inactivity, or heterodimerization with Atg14L and stimulation of autophagy. Crystallographic analyses showed that the CCDs of two Beclin1 molecules can associate with each other in an antiparallel orientation, forming a metastable structure that readily transits into a stable heterodimer complex with the CCD of Atg14L 22 . A previous study 33 and our current results demonstrate that not only does the BH3 domain of Beclin1 interact with the hydrophobic groove of Bcl-2 and/or Bcl-xL, but also the CCD of Beclin1 interacts with the BH4 domain of Bcl-2 and/or Bcl-xL. Thus, Beclin1 interacts with Bcl-2 at two sites, and the interaction at one of them is regulated by Mst1. This pattern of interactions should allow Bcl-2 to bridge two Beclin1 molecules in an Mst1-sensitive manner, with the Beclin1 homodimer further stabilized by alignment of the CCDs in an antiparallel orientation 22, 33 . As the Beclin1-Atg14L interaction was strongly enhanced by inhibition of endogenous Mst1 in vivo, Mst1-induced phosphorylation of Beclin1 and consequent stabilization of the Beclin1 homodimer may cause dissociation of Atg14L from Beclin1, thereby diminishing the activity of Vps34 in the Ag14L-Vps34 complex.
In this study, we found that Mst1 facilitates the molecular link between Beclin1 and Bcl-2, thereby not only negatively regulating autophagy but also positively regulating apoptosis by promoting sequestration of Bcl-2 family proteins from Bax. Suppression of autophagy exacerbates protein aggregation, whereas stimulation of apoptosis directly leads to decreased cardiac contractility in the failing heart (Supplementary Fig. 7) . Thus, Mst1 holds promise as a therapeutic target in heart failure.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. a r t i c l e s of the total homogenate was centrifuged at 3,500g for 20 min to separate mitochondrial fractions. To separate cytosolic fractions, the supernatant was further centrifuged at 100,000g for 60 min.
Immunoprecipitation. Cardiomyocytes were lysed with IGEPAL CA-630 buffer (50 mM Tris-HCl (pH 7.4), 1% IGEPAL CA-630, 10 mM EDTA, 150 mM NaCl, 50 mM NaF, 1 µM leupeptin and 0.1 µM aprotinin). Primary antibody was covalently immobilized on protein A/G agarose using the Pierce Crosslink Immunoprecipitation Kit according to the manufacturer's instructions (Thermo Scientific). Samples were incubated with immobilized antibody beads for at least 2 h at 4 °C. After immunoprecipitation, the samples were washed with TBS five times. They were then eluted with glycine-HCl (0.1 M, pH 3.5) and the immunoprecipitates were subjected to immunoblotting using specific primary antibodies and a conformation-specific secondary antibody that recognizes only native IgG (Cell Signaling).
Recombinant proteins.
In order to generate GST-Mst1, GST-Beclin1-WT, GST-Beclin1-N1 (amino acids 1-80), GST-Beclin1-N2 (amino acids 72-163), GST-Beclin1-MID (amino acids 150-284), GST-Beclin1-CT (amino acids 268-450), GST-Beclin1-T108A, GST-Beclin1-T108D, GST-Bcl-2-WT, GST-Bcl-2-H117A and GST-Bcl-xL, we used the pCold-GST vector 43 . Proteins fused to glutathione S-transferase (GST) were expressed in Escherichia coli strain BL21 (DE3) cultured in LB medium containing 100 µg/mL ampicillin. Protein expression was induced by addition of 1 mM isopropylthio-β-galactoside after lowering the temperature from 37 °C to 15 °C. Cells were cultured for 16 h following induction and purified with glutathione Sepharose 4B (GE Healthscience). In order to remove the N-terminal GST tag, the recombinant protein immobilized on glutathione Sepharose 4B was digested at 4 °C with GST-tagged human rhinovirus 3C protease (PreScission protease, GE Healthcare).
Pull-down binding assays. A GST-tagged fusion protein was digested to remove the GST tag, mixed with 500 µL of PBS containing 0.5% Triton X-100 and incubated for 30 min at 4 °C. A slurry of glutathione Sepharose 4B, in which a second GST-tagged fusion protein was immobilized, was added, followed by further incubation for 30 min at 4 °C. After washing three times with phosphatebuffered saline, proteins were eluted with 2× SDS sample buffer. The eluates were subjected to SDS-PAGE, and proteins were detected by immunoblot.
In vitro kinase assays. In vitro kinase assays were carried out as described with modifications 41 . Recombinant active Mst1 (10 ng, 25 µL) (Millipore) was incubated with full-length or fragmented Beclin1 (1 µg) in a kinase buffer (50 mM HEPES (pH 7.4), 15 mM MgCl 2 and 200 µM sodium vanadate containing 100 µM ATP or 5 µM ATP and 10 µCi [γ-32 P] ATP per reaction) at 30 °C for 30 min. Phosphorylated proteins were separated by SDS-PAGE and analyzed by autoradiography.
Adenovirus constructs.
Recombinant adenovirus vectors were constructed, propagated and titered as previously described 37 . Briefly, pBHGlox∆E1,3 Cre plasmid (Microbix), including the ∆E1 adenoviral genome, was co-transfected with the pDC316 shuttle vector containing the gene of interest into HEK293 cells using Lipofectamine 2000 (Life Technologies). Through homologous recombination, the test genes were integrated into the E1-deleted adenoviral genome. The viruses were propagated in HEK293 cells. We made replicationdefective human adenovirus type 5 (devoid of E1) harboring 3×Flag-Mst1-WT, 3×Flag-Beclin1-WT, Beclin1-T108A mutant, Beclin1-T108D mutant, 3×Flag-Vps34-WT, Atg14-WT-2×HA, myc-Bcl-2-WT and GFP-2×FYVE. The mutant Beclin1 plasmids were generated by site-directed mutagenesis. All mutations were verified by sequencing. The generation of adenoviruses harboring Mst1-WT, DN-Mst1 [K59R], Beclin1-WT, JNK1, GFP-LC3, mRFP-GFP-LC3 and Lats2 has been described 4, 14, 19, 44 . An in-house-generated adenovirus harboring β-galactosidase (Ad-LacZ) was used as a control.
Construction of shRNA adenoviral expression vectors.
The pSilencer 1.0-U6 expression vector was purchased from Ambion. The U6 RNA polymerase III promoter and the polylinker region were subcloned into the adenoviral shuttle vector pDC311 (Microbix). The Mst1 shRNA targeting sequence was 5′-AGACCGTGCAACTGAGGAAC-3′. The Bcl-2 shRNA targeting sequence was 5′-GGGAGAACAGGGTATGATA-3′. The Bcl-xL shRNA targeting sequence was 5′-GGAGATGCAGGTATTGGTG-3′. The Bax shRNA targeting sequence was 5′-CTCCGGCGAATTGGAGATGAA-3′. The WW45 shRNA targeting sequence was 5′-GGCTCATCACAGTCATTTT-3′. shScramble, an in-house-generated shRNA adenovirus that encodes a scramble sequence (5′-CAGTTTGGCACAATCAATA-3′), was used as control. Recombinant adenoviruses were generated by homologous recombination in HEK293 cells as described above.
Lipid kinase assay. Ad-3×Flag-Vps34, Ad-Beclin1-WT, Ad-Beclin1-T108A or Ad-Beclin1-T108D and Ad-Mst1 or Ad-LacZ were transduced into cultured neonatal rat cardiomyocytes. Cells were lysed in lysis buffer (1% IGEPAL CA-630, 20 mM Tris-HCl (pH 7.5), 137 mM NaCl, 1 mM MgC1 2 , 1 mM CaC1 2 , 100 mM NaF, 10 mM sodium pyrophosphate, 100 µM Na 3 VO 4 , 10% glycerol, 0.35 mg/mL PMSF and protease and phosphatase inhibitor cocktails). After immunoprecipitation, beads associated with the immunoprecipitated proteins were washed three times in lysis buffer, followed by three washes in a washing buffer (100 mM Tris-HCl (pH 7.4) and 500 mM LiCl) and two washes in a reaction buffer (10 mM Tris-HCl (pH 7.4), 100 mM NaCl and 1 mM EDTA). Beads were resuspended in 60 µL of reaction buffer and 10 µL of 100-mM MnCl 2 and sonicated, followed by the addition of 10 µL of 2 µg/µL phosphatidylinositol (Sigma-Aldrich). The reaction was started by the addition of ATP (10 µL of 440-µM ATP containing [γ-32 P] ATP (10 µCi, PerkinElmer), and beads were incubated for 10 min at room temperature. The reaction was terminated by adding 20 µL of 8-M HCl, and the organic phase was extracted with 160 µL chloroform/methanol (1:1). Extracted phospholipid products were resolved by TLC using a coated silica gel and a solvent composed of chloroform/ methanol/H 2 O/NH 4 OH (v/v/v/v, 9:7:1.7:0.3). Phosphorylated radioactive phosphatidylinositol 3-phosphate (PtdIns(3,4,5)P 3 ), a reaction product separated by TLC, was visualized by autoradiography. The radioactive PtdIns(3,4,5)P 3 was then excised from the thin layer plates and assayed in an LSC.
Long-lived protein degradation assay. Neonatal rat cardiomyocytes plated in 12-well plates were transduced with Ad-LacZ, Ad-Mst1, Ad-DN-Mst1 or Ad-sh-Mst1. After 48 h, intracellular proteins were labeled for 18 h at 37 °C with [ 3 H]l-valine (1 µCi/mL, PerkinElmer) in DMEM. After pulse-labeling for 24 h, cells were washed three times and cultured in DMEM supplemented with excess unlabeled valine (10 mM) for 16 h to chase out short-lived proteins. Cells were then washed and further cultured for 4 h in complete medium or Earle balanced salt solution containing unlabeled valine (10 mM). Both media and cell lysates were subjected to TCA precipitation. Long-lived protein degradation was calculated as the ratio of TCA-soluble medium to TCA-precipitated cell lysate radioactivity.
Mass spectrometry. Two peptides containing partial human Beclin1 amino acid sequences were prepared as follows: NT1 peptide (Beclin1 88-100 : MMSTESANSFTLI) and NT2 peptide (Beclin1 102-121 : EASDGGTMENLSRRLKVTGD). After a kinase reaction with Mst1, the samples were analyzed on a 4700 Proteomics Analyzer tandem mass spectrometer (Life Technologies). Positive-ion mass spectra were acquired in the reflectron mode. Tandem mass spectra of selected ions were acquired using a method optimized with 1 kV collision energy. Data analysis was performed with Data Explorer software (Life Technologies).
Immunohistochemistry. Neonatal cardiomyocytes were cultured on coverslips, transduced with adenoviruses and fixed in 4% paraformaldehyde. Mouse hearts were fixed with 4% paraformaldehyde by perfusion and sectioned at 10-µm thickness. Deparaffinized tissue sections were antigen-unmasked using citrate buffer. Samples were permeabilized with PBST (0.3% Triton X-100 in PBS), and nonspecific binding was blocked with 5% goat serum in PBST for 90 min. For immunofluorescence staining, an overnight incubation with specific antibodies was followed by 2 h of incubation with secondary antibody conjugated with Alexa Fluor 488, 555, 594 or 647 dye (Life Technologies). Samples were washed and mounted on glass slides with a reagent containing DAPI (VECTASHIELD; Vector Laboratories). Cells were observed under a fluorescence npg
